Skip to content

Phase I Study of PM54 Administered to Patients with Advanced Solid Tumors

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-517579-19-00
Acronym
PM54-A-002-24
Enrollment
105
Registered
2025-03-08
Start date
2025-03-24
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Selected Advanced Solid Tumors

Interventions

None listed

Sponsors

Pharma Mar S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026